腹主动脉瘤EVAR挑战性瘤颈纤维蛋白胶瘤囊填充的长期结局
回顾性单中心研究评估纤维蛋白胶(FS)瘤囊填充消除腹主动脉瘤EVAR后IA型内漏的安全性和长期效果。107例近端瘤颈短或成角的患者中106例内漏解决,围手术期死亡3例,中位随访89.1个月瘤囊最大直径显著缩小,10年累积生存率51.4%,无I型内漏复发等并发症。
要点
- FS瘤囊填充可有效消除挑战性瘤颈EVAR后的IA型内漏,106/107例(99.1%)解决。
- 瘤囊内压力测量可即时评估疗效,收缩压从114.1±16.7 mmHg降至59.5±20.4 mmHg(P<.01)。
- 中位随访89.1个月,瘤囊最大直径显著缩小,无I型内漏复发、远端栓塞、移位等并发症。
核心结论
- FS瘤囊填充联合瘤囊内压力测量是消除EVAR后IA型内漏的简单有效方法,尤其适用于近端瘤颈解剖挑战性患者,可能扩大EVAR适应证。
研究设计与样本
- 回顾性单中心研究,纳入2006年12月至2010年7月在上海长海医院接受传统EVAR后FS瘤囊填充以解决IA型内漏的挑战性近端瘤颈(短或成角)腹主动脉瘤患者107例。
- 患者平均年龄71.1±12.1岁,男性68例;瘤颈短(≤15 mm)83/107例(77.6%),成角(>60度)27/107例(25.2%)。
- 通过预置导管测量FS填充前后瘤囊内压力以观察即时疗效,并通过每年主动脉CTA评估7-10年长期效果(内漏、瘤囊最大直径、全因死亡率及其他严重并发症)。
主要发现
- 107例内漏中106例(99.1%)解决,围手术期死亡3例(2.8%)。
- 治疗病例瘤囊内收缩压、舒张压、平均压和脉压均显著下降(收缩压114.1±16.7 mmHg vs 59.5±20.4 mmHg;舒张压65.0±10.4 mmHg vs 51.4±18.2 mmHg;平均压81.3±11.4 mmHg vs 54.1±18.8 mmHg;脉压49.1±12.8 mmHg vs 8.2±5.2 mmHg;P<.01)。
- 中位随访89.1个月,瘤囊最大直径较术前显著缩小(53.23±10.9 mm vs 59.86±11.77 mm);术后瘤囊最大直径在76例患者中缩小,22例稳定。
- 1例因IV型内漏瘤囊增大转开放手术,1例CTA未见瘤囊内血流密切随访;4例发生IB型内漏和瘤囊增大后接受重复血管内治疗。
- 中位随访89.1个月,术后1、3、6、8、10年累积生存率分别为90.7%、80.4%、72.0%、58.9%、51.4%;围手术期和随访期间无I型内漏复发、远端栓塞、移位、扭结或FS注射后功能障碍。
临床怎么用
- 对于近端瘤颈短或成角的腹主动脉瘤患者,EVAR后如出现IA型内漏,可考虑FS瘤囊填充联合瘤囊内压力测量作为补救措施。
- 术中瘤囊内压力测量有助于即时确认FS填充的疗效。
- 术后需长期年度CTA随访,监测内漏、瘤囊直径变化及远期并发症。
局限性
- 回顾性单中心研究,样本量有限(107例),结果需多中心验证。
- 随访期间部分患者接受再次干预,可能影响长期结局解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A retrospective single-center study is reported here to assess the safety and long-term effectiveness of applying a fibrin sealant (FS) sac-filling strategy to eliminate type IA endoleak (TIAE) after endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm. METHODS: Characteristics of abdominal aortic aneurysm patients who had challenging proximal aortic neck anatomy (short or angulated) and underwent FS sac filling to resolve TIAE after traditional EVAR in Changhai Hospital between December 2006 and July 2010 were collected and reviewed. Intrasac pressure was measured with a preloaded catheter before and after FS filling to observe the immediate curative effect. The 7- to 10-year long-term effect was evaluated on the basis of the occurrence of endoleak, maximum aneurysm diameter, all-cause mortality, and other severe complications by annual aortic computed tomography angiography check. RESULTS: There were 107 patients with short (≤15 mm; 83/107 [77.6%]) or angulated (>60 degrees; 27/107 [25.2%]) aneurysm neck who underwent FS sac filling. The mean age of the patients was 71.1 ± 12.1 years (68 male patients). Of the 107 endoleaks, 106 (106/107 [99.1%]) were resolved, and 3 (3/107 [2.8%]) patients died in the perioperative period. Intrasac systolic, diastolic, mean, and pulse pressures decreased significantly in the treated cases (systolic pressure, 114.1 ± 16.7 mm Hg vs 59.5 ± 20.4 mm Hg; diastolic pressure, 65.0 ± 10.4 mm Hg vs 51.4 ± 18.2 mm Hg; mean pressure, 81.3 ± 11.4 mm Hg vs 54.1 ± 18.8 mm Hg; pulse pressure, 49.1 ± 12.8 mm Hg vs 8.2 ± 5.2 mm Hg; P < .01). During a median follow-up period of 89.1 months, the mean maximum aneurysm diameter became significantly smaller than that observed before the operation (53.23 ± 10.9 mm vs 59.86 ± 11.77 mm). The postoperative maximum aneurysm diameter decreased in 76 patients and was stable in 22 patients. One patient with aneurysm enlargement was transferred to open surgery because of a type IV endoleak, and another patient with no blood flow into the aneurysm sac observed by computed tomography angiography was closely followed up. Four patients received repeated endovascular treatment after the occurrence of type IB endoleak and aneurysm enlargement. After a median follow-up of 89.1 months, the cumulative survival rate was 90.7%, 80.4%, 72.0%, 58.9%, and 51.4% after 1 year, 3 years, 6 years, 8 years, and 10 years after the operation, respectively. There was no recurrent type I endoleak, distal embolization, migration, kinking, or malfunction after FS injections during the perioperative period and follow-up. CONCLUSIONS: FS sac filling combined with intrasac pressure measurement is a simple and effective treatment method to eliminate TIAE after EVAR, especially for patients with challenging proximal neck anatomy. This method could expand the current indications of EVAR.
引用
- Zhang L, Zhao W, Wu MT, et al. Long-term outcome of sac filling with fibrin sealant after endovascular aneurysm repair of abdominal aortic aneurysm with challenging aortic neck anatomy. J Vasc Surg. 2019. PMID: 30777688. doi:10.1016/j.jvs.2018.10.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。